Bioworks raises an additional 415 million yen in funding. Bringing total raised capital to 2.5 billion yen.


Bioworks Corporation(Headquarters: Soraku-gun, Kyoto; CEO: Yukihiro Imai; hereinafter referred to as Bioworks)has successfully conducted a third-party allotment of new shares to international venture capital firms, Lavender Hill Capital (Headquarters: Hong Kong, China; Founding Partner: Xiaoyin Zhang;hereinafter referred to as Lavender Hill), Purpose Venture Capital (Headquarters: Singapore; Co-Founders: Sharon Sim, Sertac Yeltekin, and Von Leong), 18 Salisbury Capital (based in Hong Kong and Tokyo; Founding Partners: Stephen Yuen, Masanori Takaku, Terufumi Hamazaki), as well as to textile trading company Yagi & Co (Headquarters: Chuo-ku, Tokyo; Representative Director, President and Chief Executive Officer: Takao Yagi; hereinafter referred to as “Yagi”), and other investors.

With this latest funding, Bioworks has successfully raised a cumulative total of 2.5 billion yen. The raised capital will be utilized by Bioworks to strengthen its R&D and human resources, expand its product portfolio, enter new markets, and expand its business both domestically and internationally.